Deal Tracker · Regions

Southeast Asia pharma distribution deals

5 distribution deals in Southeast Asia tracked by EPT (2026). Most active: Korea United Pharm, Abbott, Dai Nam Ha Noi & Duopharma Biotech. Latest: Novo Nordisk → Abbott (Distribution, 5 Nov 2026).

5
deals tracked
7
countries involved
$37.3m
disclosed value (3 deals)
100%
distribution, the top deal type
  • EPT has tracked 5 Southeast Asia pharma distribution deals (2026).
  • The countries that appear most often are South Korea (3), Malaysia (2), Philippines (2) & United States (2).
  • Values were disclosed for 3 of 5 deals, totalling $37.3m; the largest is Hanmi Pharmaceutical → Organon ($34m, 21 May 2026).
  • The most active companies: Korea United Pharm (2).

Most active companies

Korea United Pharm (2)

Countries involved

South Korea (3) · Malaysia (2) · Philippines (2) · United States (2) · Denmark (1) · Taiwan (1)

Largest disclosed deals

Questions

How many Southeast Asia pharma distribution deals has EPT tracked?
5 as of 5 Nov 2026, covering 2026. The most recent is Novo Nordisk → Abbott (Distribution, 5 Nov 2026).
Which companies are most active in Southeast Asia pharma distribution deals?
Korea United Pharm (2 deals).
What is the largest disclosed Southeast Asia pharma distribution deal?
Hanmi Pharmaceutical → Organon: $34m (Distribution, 21 May 2026); Korea United Pharm → Qualimed Pharma: $2.5m (Distribution, 23 Oct 2026); Korea United Pharm → Dai Nam Ha Noi: $0.8m (Distribution, 23 Oct 2026). Values are as announced by the parties.
Which countries appear most in Southeast Asia pharma distribution deals?
South Korea (3), Malaysia (2), Philippines (2), United States (2), Denmark (1), Taiwan (1) — counting where the parties are based and the markets the deals cover.

Browse deals

By region

GCC (83) · MENA (66) · Africa (17) · Latin America (17) · Southeast Asia (17) · Global (LMICs) (14) · CIS & Central Asia (13) · Türkiye (5) · Global ex-US (1)

By country

Saudi Arabia (69) · UAE (61) · China (31) · Egypt (27) · United States (26) · Oman (20) · India (19) · Switzerland (18) · Jordan (14) · South Korea (14) · Kazakhstan (13) · Algeria (12) · Türkiye (12) · United Kingdom (11) · Brazil (10) · Kuwait (10) · Iraq (8) · Morocco (8) · Bahrain (7) · Malaysia (7) · Spain (7) · Argentina (6) · Germany (6) · Indonesia (6) · Philippines (6) · Qatar (6) · Italy (5) · Mexico (5) · Vietnam (5) · France (4) · Taiwan (4) · Tunisia (4) · Canada (3) · Chile (3) · Denmark (3) · Greece (3) · Japan (3) · Lebanon (3) · Nigeria (3) · Pakistan (3) · South Africa (3) · Sweden (3) · Thailand (3) · Azerbaijan (2) · Colombia (2) · Ireland (2) · Kenya (2) · Libya (2) · Netherlands (2) · Singapore (2) · Uruguay (2) · Uzbekistan (2)

By year

2026 (193) · 2025 (27) · 2024 (6) · 2022 (3) · 2021 (2)

By therapeutic area

Multi-therapy (64) · Oncology (30) · Metabolic / Diabetes (27) · Cardiovascular (17) · Vaccines (15) · Immunology / Inflammation (13) · Rare / Orphan (9) · Infectious Disease (8) · CNS / Neurology (6) · Ophthalmology (6) · Consumer health (5) · Women's Health (4) · Respiratory (2)